LL-37 5mg peptide
LL-37 5mg peptide: a research vial of LL-37, a 37 amino acid peptide the body makes against germs, tested in two small leg ulcer trials; Peptides Hanoi links five PubMed papers on it, from 2014 to 2024, three of them reviews.
3,000,000 VND ($120 USD) for 1 vial
Stock and the total are confirmed on WhatsApp.
USD prices are the store's dollar prices; you pay the VND price.
Free tracked delivery to Hanoi in 1 to 3 days, no minimum order. Each vial comes with a bottle of bacteriostatic water and a container. Research use only: not an approved medicine, and no medical advice.
What is LL-37?
LL-37 5mg is a germ-fighting peptide of 37 amino acids that the body makes for itself. Laboratories have studied it closely, and two small human trials have tested an LL-37 product.
Humans make just one cathelicidin, a family of germ-fighting peptides, and LL-37 is it. It is released by immune cells and by the cells that line the body's surfaces.
In lab work it attacks bacteria head-on and also talks to the immune system, which keeps researchers busy.
What the 5 PubMed papers cited for LL-37 looked at, 2014 to 2024
According to a 2016 review of lab studies, LL-37 tears holes in bacteria and alerts the immune system, and it can push inflammation either way.
Another review from the same year covered LL-37 research in the immune system, the lungs, the gut and the skin, and asked for more study.
Leg ulcers that would not close were the test in two randomised trials of an LL-37 product: one in 2014 with 34 patients, and a larger one in 2021 with 148 patients, against placebo. Both measured how the wounds closed, and the larger 2021 trial found no overall difference from placebo.
A 2024 skin review adds two cautions: peptides of this kind have often fallen short in clinical trials, and some bacteria resist them.
Sources: Biochim Biophys Acta 2016; Pharmacol Rep 2016; Wound Repair Regen 2014; Wound Repair Regen 2021; Antibiotics (Basel) 2024.
Reading the LL-37 record
LL-37 shows how much lab work can sit behind a small human record. In the lab it breaks open bacteria and calls in immune cells. In people, the record is two leg ulcer trials of one product.
The two trials differ in size: the 2021 trial took in 148 people, more than four times the 34 in the 2014 one. Reading one without the other would give half the record.
A 2016 review notes that LL-37 can push inflammation either way. The 2024 review adds that many peptides like it have fallen short in clinical trials, and that some bacteria resist them.
The 2024 review is worth reading in full for anyone weighing this peptide. It sets out both the lab work and the reasons such peptides have struggled in clinical trials.
Questions about LL-37
Does the human body make LL-37?
It does. LL-37 is the single cathelicidin humans produce, and immune and lining cells release it to fight germs.
How were the LL-37 ulcer trials run?
Both were randomised trials of an LL-37 product on leg ulcers that would not close: 34 patients in 2014 and 148 in 2021, against placebo. The 2021 trial found no overall difference from placebo.
Do bacteria ever resist LL-37?
A 2024 skin review says some do.
LL-37 5mg prices
| Pack | Total | Each vial | Per mg |
|---|---|---|---|
| 1 vial | 3,000,000 VND ($120 USD) | 3,000,000 VND ($120 USD) | 600,000 VND ($24.00 USD) |
| Pack of 3 | 7,290,000 VND ($291.60 USD) | 2,430,000 VND ($97.20 USD) | 486,000 VND ($19.44 USD) |
| Pack of 5 | 10,800,000 VND ($432 USD) | 2,160,000 VND ($86.40 USD) | 432,000 VND ($17.28 USD) |
| Pack of 10 | 18,000,000 VND ($720 USD) | 1,800,000 VND ($72 USD) | 360,000 VND ($14.40 USD) |
Near LL-37 in the list of 42
LL-37 follows KPV 10mg and comes before Thymosin Alpha-1 10mg, a peptide from the thymus gland.
- KLOW 80mg, 5,300,000 VND ($210 USD) a vial
- KPV 10mg, 2,400,000 VND ($95 USD) a vial
- Thymosin Alpha-1 10mg, 3,900,000 VND ($155 USD) a vial
- Thymalin 10mg, 2,400,000 VND ($95 USD) a vial